Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-15 Super Agonist ALT-803 in Human Immunodeficiency Virus (HIV)

NCT03899480 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT03899480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Transfer of Haploidentical Natural Killer Cells and IL-15 Super Agonist ALT-803 in Human Immunodeficiency Virus (HIV)
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
May 1, 2019
Completion date
April 1, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv infections, immune deficiency